rs76308115
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The ENST00000286063.11(PDE11A):c.919C>T(p.Arg307Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00426 in 1,611,942 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000286063.11 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE11A | NM_016953.4 | c.919C>T | p.Arg307Ter | stop_gained | 2/20 | ENST00000286063.11 | NP_058649.3 | |
PDE11A | NM_001077197.2 | c.169C>T | p.Arg57Ter | stop_gained | 3/21 | NP_001070665.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE11A | ENST00000286063.11 | c.919C>T | p.Arg307Ter | stop_gained | 2/20 | 1 | NM_016953.4 | ENSP00000286063 | P1 | |
PDE11A | ENST00000358450.8 | c.169C>T | p.Arg57Ter | stop_gained | 3/21 | 1 | ENSP00000351232 |
Frequencies
GnomAD3 genomes AF: 0.00289 AC: 440AN: 152126Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00288 AC: 721AN: 250432Hom.: 4 AF XY: 0.00286 AC XY: 387AN XY: 135368
GnomAD4 exome AF: 0.00440 AC: 6426AN: 1459698Hom.: 16 Cov.: 29 AF XY: 0.00428 AC XY: 3112AN XY: 726300
GnomAD4 genome AF: 0.00290 AC: 441AN: 152244Hom.: 2 Cov.: 33 AF XY: 0.00271 AC XY: 202AN XY: 74424
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 02, 2019 | This variant is associated with the following publications: (PMID: 18559625, 20351491, 25525159, 23771924, 26820475, 21047926, 16767104, 29495593, 30262796, 32098292) - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PDE11A p.Arg57X variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs76308115), Cosmic (FATHMM prediction score of neutral) and ClinVar (classified as likely benign by GeneDx and pathogenic by Genomic Research Center, Shahid Beheshti University of Medical Sciences for pigmented nodular adrenocortical disease, 2). The variant was identified in control databases in 849 of 281828 chromosomes (5 homozygous) at a frequency of 0.003012 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 613 of 128514 chromosomes (freq: 0.00477), Other in 26 of 7184 chromosomes (freq: 0.003619), European (Finnish) in 73 of 25042 chromosomes (freq: 0.002915), Ashkenazi Jewish in 25 of 10350 chromosomes (freq: 0.002415), South Asian in 41 of 30580 chromosomes (freq: 0.001341), Latino in 43 of 35376 chromosomes (freq: 0.001216) and African in 28 of 24956 chromosomes (freq: 0.001122); it was not observed in the East Asian population. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Arg57X variant leads to a premature stop codon at position 57 which is predicted to lead to a truncated or absent protein and loss of function. Other loss of function variants (c.919C>T, p.R317X) have been identified in the PDE11A gene as causal for Cushing Syndrome and ovarian cysts (Hovarth_2006_PMID: 16767104), indicating that stop gain variants in the PDE11A gene are disease-causing. Further, MutationTaster predicts the variant to be disease causing. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PDE11A: BS1, BS2 - |
Pigmented nodular adrenocortical disease, primary, 2 Pathogenic:2
Pathogenic, flagged submission | literature only | OMIM | Jul 01, 2006 | - - |
Pathogenic, flagged submission | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 03, 2017 | - - |
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Nov 02, 2020 | ACMG classification criteria: PVS1, BS1 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at